- call +1-201-465-4211
- email sales@marketsandresearch.biz
- Call +1-201-465-4211
- Email: sales@marketsandresearch.biz
Market Overview
The NGS-based RNA-seq market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
The global NGS-based RNA-seq market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 10.9%% in the forecast period of 2020 to 2025 and will expected to reach USD 2189.5 million by 2025, from USD 1450 million in 2019.
Market segmentation
NGS-based RNA-seq market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, NGS-based RNA-seq market has been segmented into:
High-Throughput Sequencing
Third-Generation Sequencing Technology
By Application, NGS-based RNA-seq has been segmented into:
Hospitals and Clinics
Biopharma Companies
Government Agencies
Academic and Research Organizations
Other
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global NGS-based RNA-seq market presented in the report. This section sheds light on the sales growth of different regional and country-level NGS-based RNA-seq markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global NGS-based RNA-seq market.
The report offers in-depth assessment of the growth and other aspects of the NGS-based RNA-seq market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Competitive Landscape and NGS-based RNA-seq Market Share Analysis
NGS-based RNA-seq competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, NGS-based RNA-seq sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the NGS-based RNA-seq sales, revenue and market share for each player covered in this report.
The major players covered in NGS-based RNA-seq are:
Illumina
Perkinelmer
Qaigen
Thermo Fisher Scientific
Oxford Nanopore Technologies
Pacific Biosciences Of California
Gatc Biotech
Agilent Technologies
F. Hoffmann-La Roche
Eurofins Scientific
Macrogen
Among other players domestic and global, NGS-based RNA-seq market share data is available for global, North America, Europe, Asia-Pacific, Middle East & Africa and South America separately. Our analysts understand competitive strengths and provide competitive analysis for each competitor separately.
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 NGS-based RNA-seq Market Overview
1.1 Product Overview and Scope of NGS-based RNA-seq
1.2 Classification of NGS-based RNA-seq by Type
1.2.1 Global NGS-based RNA-seq Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global NGS-based RNA-seq Revenue Market Share by Type in 2019
1.2.3 High-Throughput Sequencing
1.2.4 Third-Generation Sequencing Technology
1.3 Global NGS-based RNA-seq Market by Application
1.3.1 Overview: Global NGS-based RNA-seq Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Hospitals and Clinics
1.3.3 Biopharma Companies
1.3.4 Government Agencies
1.3.5 Academic and Research Organizations
1.3.6 Other
1.4 Global NGS-based RNA-seq Market by Regions
1.4.1 Global NGS-based RNA-seq Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of NGS-based RNA-seq (2015-2025)
1.4.3 North America (USA, Canada and Mexico) NGS-based RNA-seq Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) NGS-based RNA-seq Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) NGS-based RNA-seq Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) NGS-based RNA-seq Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) NGS-based RNA-seq Status and Prospect (2015-2025)
2 Company Profiles
2.1 Illumina
2.1.1 Illumina Details
2.1.2 Illumina Major Business
2.1.3 Illumina SWOT Analysis
2.1.4 Illumina Product and Services
2.1.5 Illumina NGS-based RNA-seq Revenue, Gross Margin and Market Share (2018-2019)
2.2 Perkinelmer
2.2.1 Perkinelmer Details
2.2.2 Perkinelmer Major Business
2.2.3 Perkinelmer SWOT Analysis
2.2.4 Perkinelmer Product and Services
2.2.5 Perkinelmer NGS-based RNA-seq Revenue, Gross Margin and Market Share (2018-2019)
2.3 Qaigen
2.3.1 Qaigen Details
2.3.2 Qaigen Major Business
2.3.3 Qaigen SWOT Analysis
2.3.4 Qaigen Product and Services
2.3.5 Qaigen NGS-based RNA-seq Revenue, Gross Margin and Market Share (2018-2019)
2.4 Thermo Fisher Scientific
2.4.1 Thermo Fisher Scientific Details
2.4.2 Thermo Fisher Scientific Major Business
2.4.3 Thermo Fisher Scientific SWOT Analysis
2.4.4 Thermo Fisher Scientific Product and Services
2.4.5 Thermo Fisher Scientific NGS-based RNA-seq Revenue, Gross Margin and Market Share (2018-2019)
2.5 Oxford Nanopore Technologies
2.5.1 Oxford Nanopore Technologies Details
2.5.2 Oxford Nanopore Technologies Major Business
2.5.3 Oxford Nanopore Technologies SWOT Analysis
2.5.4 Oxford Nanopore Technologies Product and Services
2.5.5 Oxford Nanopore Technologies NGS-based RNA-seq Revenue, Gross Margin and Market Share (2018-2019)
2.6 Pacific Biosciences Of California
2.6.1 Pacific Biosciences Of California Details
2.6.2 Pacific Biosciences Of California Major Business
2.6.3 Pacific Biosciences Of California Product and Services
2.6.4 Pacific Biosciences Of California NGS-based RNA-seq Revenue, Gross Margin and Market Share (2018-2019)
2.7 Gatc Biotech
2.7.1 Gatc Biotech Details
2.7.2 Gatc Biotech Major Business
2.7.3 Gatc Biotech Product and Services
2.7.4 Gatc Biotech NGS-based RNA-seq Revenue, Gross Margin and Market Share (2018-2019)
2.8 Agilent Technologies
2.8.1 Agilent Technologies Details
2.8.2 Agilent Technologies Major Business
2.8.3 Agilent Technologies Product and Services
2.8.4 Agilent Technologies NGS-based RNA-seq Revenue, Gross Margin and Market Share (2018-2019)
2.9 F. Hoffmann-La Roche
2.9.1 F. Hoffmann-La Roche Details
2.9.2 F. Hoffmann-La Roche Major Business
2.9.3 F. Hoffmann-La Roche Product and Services
2.9.4 F. Hoffmann-La Roche NGS-based RNA-seq Revenue, Gross Margin and Market Share (2018-2019)
2.10 Eurofins Scientific
2.10.1 Eurofins Scientific Details
2.10.2 Eurofins Scientific Major Business
2.10.3 Eurofins Scientific Product and Services
2.10.4 Eurofins Scientific NGS-based RNA-seq Revenue, Gross Margin and Market Share (2018-2019)
2.11 Macrogen
2.11.1 Macrogen Details
2.11.2 Macrogen Major Business
2.11.3 Macrogen Product and Services
2.11.4 Macrogen NGS-based RNA-seq Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global NGS-based RNA-seq Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 NGS-based RNA-seq Players Market Share
3.2.2 Top 10 NGS-based RNA-seq Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global NGS-based RNA-seq Revenue and Market Share by Regions
4.2 North America NGS-based RNA-seq Revenue and Growth Rate (2015-2020)
4.3 Europe NGS-based RNA-seq Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific NGS-based RNA-seq Revenue and Growth Rate (2015-2020)
4.5 South America NGS-based RNA-seq Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa NGS-based RNA-seq Revenue and Growth Rate (2015-2020)
5 North America NGS-based RNA-seq Revenue by Countries
5.1 North America NGS-based RNA-seq Revenue by Countries (2015-2020)
5.2 USA NGS-based RNA-seq Revenue and Growth Rate (2015-2020)
5.3 Canada NGS-based RNA-seq Revenue and Growth Rate (2015-2020)
5.4 Mexico NGS-based RNA-seq Revenue and Growth Rate (2015-2020)
6 Europe NGS-based RNA-seq Revenue by Countries
6.1 Europe NGS-based RNA-seq Revenue by Countries (2015-2020)
6.2 Germany NGS-based RNA-seq Revenue and Growth Rate (2015-2020)
6.3 UK NGS-based RNA-seq Revenue and Growth Rate (2015-2020)
6.4 France NGS-based RNA-seq Revenue and Growth Rate (2015-2020)
6.5 Russia NGS-based RNA-seq Revenue and Growth Rate (2015-2020)
6.6 Italy NGS-based RNA-seq Revenue and Growth Rate (2015-2020)
7 Asia-Pacific NGS-based RNA-seq Revenue by Regions
7.1 Asia-Pacific NGS-based RNA-seq Revenue by Regions (2015-2020)
7.2 China NGS-based RNA-seq Revenue and Growth Rate (2015-2020)
7.3 Japan NGS-based RNA-seq Revenue and Growth Rate (2015-2020)
7.4 Korea NGS-based RNA-seq Revenue and Growth Rate (2015-2020)
7.5 India NGS-based RNA-seq Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia NGS-based RNA-seq Revenue and Growth Rate (2015-2020)
8 South America NGS-based RNA-seq Revenue by Countries
8.1 South America NGS-based RNA-seq Revenue by Countries (2015-2020)
8.2 Brazil NGS-based RNA-seq Revenue and Growth Rate (2015-2020)
8.3 Argentina NGS-based RNA-seq Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue NGS-based RNA-seq by Countries
9.1 Middle East & Africa NGS-based RNA-seq Revenue by Countries (2015-2020)
9.2 Saudi Arabia NGS-based RNA-seq Revenue and Growth Rate (2015-2020)
9.3 UAE NGS-based RNA-seq Revenue and Growth Rate (2015-2020)
9.4 Egypt NGS-based RNA-seq Revenue and Growth Rate (2015-2020)
9.5 South Africa NGS-based RNA-seq Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global NGS-based RNA-seq Revenue and Market Share by Type (2015-2020)
10.2 Global NGS-based RNA-seq Market Forecast by Type (2019-2024)
10.3 High-Throughput Sequencing Revenue Growth Rate (2015-2025)
10.4 Third-Generation Sequencing Technology Revenue Growth Rate (2015-2025)
11 Global NGS-based RNA-seq Market Segment by Application
11.1 Global NGS-based RNA-seq Revenue Market Share by Application (2015-2020)
11.2 NGS-based RNA-seq Market Forecast by Application (2019-2024)
11.3 Hospitals and Clinics Revenue Growth (2015-2020)
11.4 Biopharma Companies Revenue Growth (2015-2020)
11.5 Government Agencies Revenue Growth (2015-2020)
11.6 Academic and Research Organizations Revenue Growth (2015-2020)
11.7 Other Revenue Growth (2015-2020)
12 Global NGS-based RNA-seq Market Size Forecast (2021-2025)
12.1 Global NGS-based RNA-seq Market Size Forecast (2021-2025)
12.2 Global NGS-based RNA-seq Market Forecast by Regions (2021-2025)
12.3 North America NGS-based RNA-seq Revenue Market Forecast (2021-2025)
12.4 Europe NGS-based RNA-seq Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific NGS-based RNA-seq Revenue Market Forecast (2021-2025)
12.6 South America NGS-based RNA-seq Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa NGS-based RNA-seq Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US
List of Tables
Table 1. Global NGS-based RNA-seq Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of NGS-based RNA-seq by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global NGS-based RNA-seq Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market NGS-based RNA-seq Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Global NGS-based RNA-seq Market Size and Growth Estimation in Various Scenarios in 2020
Table 6. Illumina Corporate Information, Location and Competitors
Table 7. Illumina NGS-based RNA-seq Major Business
Table 8. Illumina NGS-based RNA-seq Total Revenue (USD Million) (2017-2018)
Table 9. Illumina SWOT Analysis
Table 10. Illumina NGS-based RNA-seq Product and Solutions
Table 11. Illumina NGS-based RNA-seq Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 12. Perkinelmer Corporate Information, Location and Competitors
Table 13. Perkinelmer NGS-based RNA-seq Major Business
Table 14. Perkinelmer NGS-based RNA-seq Total Revenue (USD Million) (2018-2019)
Table 15. Perkinelmer SWOT Analysis
Table 16. Perkinelmer NGS-based RNA-seq Product and Solutions
Table 17. Perkinelmer NGS-based RNA-seq Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 18. Qaigen Corporate Information, Location and Competitors
Table 19. Qaigen NGS-based RNA-seq Major Business
Table 20. Qaigen NGS-based RNA-seq Total Revenue (USD Million) (2017-2018)
Table 21. Qaigen SWOT Analysis
Table 22. Qaigen NGS-based RNA-seq Product and Solutions
Table 23. Qaigen NGS-based RNA-seq Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 24. Thermo Fisher Scientific Corporate Information, Location and Competitors
Table 25. Thermo Fisher Scientific NGS-based RNA-seq Major Business
Table 26. Thermo Fisher Scientific NGS-based RNA-seq Total Revenue (USD Million) (2017-2018)
Table 27. Thermo Fisher Scientific SWOT Analysis
Table 28. Thermo Fisher Scientific NGS-based RNA-seq Product and Solutions
Table 29. Thermo Fisher Scientific NGS-based RNA-seq Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 30. Oxford Nanopore Technologies Corporate Information, Location and Competitors
Table 31. Oxford Nanopore Technologies NGS-based RNA-seq Major Business
Table 32. Oxford Nanopore Technologies NGS-based RNA-seq Total Revenue (USD Million) (2017-2018)
Table 33. Oxford Nanopore Technologies SWOT Analysis
Table 34. Oxford Nanopore Technologies NGS-based RNA-seq Product and Solutions
Table 35. Oxford Nanopore Technologies NGS-based RNA-seq Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 36. Pacific Biosciences Of California Corporate Information, Location and Competitors
Table 37. Pacific Biosciences Of California NGS-based RNA-seq Major Business
Table 38. Pacific Biosciences Of California NGS-based RNA-seq Total Revenue (USD Million) (2017-2018)
Table 39. Pacific Biosciences Of California SWOT Analysis
Table 40. Pacific Biosciences Of California NGS-based RNA-seq Product and Solutions
Table 41. Pacific Biosciences Of California NGS-based RNA-seq Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 42. Gatc Biotech Corporate Information, Location and Competitors
Table 43. Gatc Biotech NGS-based RNA-seq Major Business
Table 44. Gatc Biotech NGS-based RNA-seq Total Revenue (USD Million) (2017-2018)
Table 45. Gatc Biotech SWOT Analysis
Table 46. Gatc Biotech NGS-based RNA-seq Product and Solutions
Table 47. Gatc Biotech NGS-based RNA-seq Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 48. Agilent Technologies Corporate Information, Location and Competitors
Table 49. Agilent Technologies NGS-based RNA-seq Major Business
Table 50. Agilent Technologies NGS-based RNA-seq Total Revenue (USD Million) (2017-2018)
Table 51. Agilent Technologies SWOT Analysis
Table 52. Agilent Technologies NGS-based RNA-seq Product and Solutions
Table 53. Agilent Technologies NGS-based RNA-seq Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 54. F. Hoffmann-La Roche Corporate Information, Location and Competitors
Table 55. F. Hoffmann-La Roche NGS-based RNA-seq Major Business
Table 56. F. Hoffmann-La Roche NGS-based RNA-seq Total Revenue (USD Million) (2017-2018)
Table 57. F. Hoffmann-La Roche SWOT Analysis
Table 58. F. Hoffmann-La Roche NGS-based RNA-seq Product and Solutions
Table 59. F. Hoffmann-La Roche NGS-based RNA-seq Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 60. Eurofins Scientific Corporate Information, Location and Competitors
Table 61. Eurofins Scientific NGS-based RNA-seq Major Business
Table 62. Eurofins Scientific NGS-based RNA-seq Total Revenue (USD Million) (2017-2018)
Table 63. Eurofins Scientific SWOT Analysis
Table 64. Eurofins Scientific NGS-based RNA-seq Product and Solutions
Table 65. Eurofins Scientific NGS-based RNA-seq Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 66. Macrogen Corporate Information, Location and Competitors
Table 67. Macrogen NGS-based RNA-seq Major Business
Table 68. Macrogen NGS-based RNA-seq Total Revenue (USD Million) (2017-2018)
Table 69. Macrogen SWOT Analysis
Table 70. Macrogen NGS-based RNA-seq Product and Solutions
Table 71. Macrogen NGS-based RNA-seq Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 72. Global NGS-based RNA-seq Revenue (Million USD) by Players (2015-2020)
Table 73. Global NGS-based RNA-seq Revenue Share by Players (2015-2020)
Table 74. Global NGS-based RNA-seq Revenue (Million USD) by Regions (2015-2020)
Table 75. Global NGS-based RNA-seq Revenue Market Share by Regions (2015-2020)
Table 76. North America NGS-based RNA-seq Revenue by Countries (2015-2020)
Table 77. North America NGS-based RNA-seq Revenue Market Share by Countries (2015-2020)
Table 78. Europe NGS-based RNA-seq Revenue (Million USD) by Countries (2015-2020)
Table 79. Asia-Pacific NGS-based RNA-seq Revenue (Million USD) by Regions (2015-2020)
Table 80. South America NGS-based RNA-seq Revenue by Countries (2015-2020)
Table 81. South America NGS-based RNA-seq Revenue Market Share by Countries (2015-2020)
Table 82. Middle East and Africa NGS-based RNA-seq Revenue (Million USD) by Countries (2015-2020)
Table 83. Middle East and Africa NGS-based RNA-seq Revenue Market Share by Countries (2015-2020)
Table 84. Global NGS-based RNA-seq Revenue (Million USD) by Type (2015-2020)
Table 85. Global NGS-based RNA-seq Revenue Share by Type (2015-2020)
Table 86. Global NGS-based RNA-seq Revenue Forecast by Type (2021-2025)
Table 87. Global NGS-based RNA-seq Revenue by Application (2015-2020)
Table 88. Global NGS-based RNA-seq Revenue Share by Application (2015-2020)
Table 89. Global NGS-based RNA-seq Revenue Forecast by Application (2021-2025)
Table 90. Global NGS-based RNA-seq Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. NGS-based RNA-seq Picture
Figure 2. Global NGS-based RNA-seq Revenue Market Share by Type in 2019
Figure 3. High-Throughput Sequencing Picture
Figure 4. Third-Generation Sequencing Technology Picture
Figure 5. NGS-based RNA-seq Revenue Market Share by Application in 2019
Figure 6. Hospitals and Clinics Picture
Figure 7. Biopharma Companies Picture
Figure 8. Government Agencies Picture
Figure 9. Academic and Research Organizations Picture
Figure 10. Other Picture
Figure 11. Global NGS-based RNA-seq Revenue (USD Million) and Growth Rate (2015-2025)
Figure 12. North America NGS-based RNA-seq Revenue (Million USD) and Growth Rate (2015-2025)
Figure 13. Europe NGS-based RNA-seq Revenue (Million USD) and Growth Rate (2015-2025)
Figure 14. Asia-Pacific NGS-based RNA-seq Revenue (Million USD) and Growth Rate (2015-2025)
Figure 15. South America NGS-based RNA-seq Revenue (Million USD) and Growth Rate (2015-2025)
Figure 16. Middle East and Africa NGS-based RNA-seq Revenue (Million USD) and Growth Rate (2015-2025)
Figure 17. Global NGS-based RNA-seq Revenue (Million USD) and Growth Rate (2015-2025)
Figure 18. Global NGS-based RNA-seq Revenue Share by Players in 2019
Figure 19. Global Top 5 Players NGS-based RNA-seq Revenue Market Share in 2019
Figure 20. Global Top 10 Players NGS-based RNA-seq Revenue Market Share in 2019
Figure 21. Key Players Market Share Trend
Figure 22. Global NGS-based RNA-seq Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 23. Global NGS-based RNA-seq Revenue Market Share by Regions (2015-2020)
Figure 24. Global NGS-based RNA-seq Revenue Market Share by Regions in 2018
Figure 25. North America NGS-based RNA-seq Revenue and Growth Rate (2015-2020)
Figure 26. Europe NGS-based RNA-seq Revenue and Growth Rate (2015-2020)
Figure 27. Asia-Pacific NGS-based RNA-seq Revenue and Growth Rate (2015-2020)
Figure 28. South America NGS-based RNA-seq Revenue and Growth Rate (2015-2020)
Figure 29. Middle East and Africa NGS-based RNA-seq Revenue and Growth Rate (2015-2020)
Figure 30. North America NGS-based RNA-seq Revenue Market Share by Countries (2015-2020)
Figure 31. North America NGS-based RNA-seq Revenue Market Share by Countries in 2019
Figure 32. USA NGS-based RNA-seq Revenue and Growth Rate (2015-2020)
Figure 33. Canada NGS-based RNA-seq Revenue and Growth Rate (2015-2020)
Figure 34. Mexico NGS-based RNA-seq Revenue and Growth Rate (2015-2020)
Figure 35. Europe NGS-based RNA-seq Revenue Market Share by Countries (2015-2020)
Figure 36. Europe NGS-based RNA-seq Revenue Market Share by Countries in 2019
Figure 37. Germany NGS-based RNA-seq Revenue and Growth Rate (2015-2020)
Figure 38. UK NGS-based RNA-seq Revenue and Growth Rate (2015-2020)
Figure 39. France NGS-based RNA-seq Revenue and Growth Rate (2015-2020)
Figure 40. Russia NGS-based RNA-seq Revenue and Growth Rate (2015-2020)
Figure 41. Italy NGS-based RNA-seq Revenue and Growth Rate (2015-2020)
Figure 42. Asia-Pacific NGS-based RNA-seq Revenue Market Share by Regions (2015-2020)
Figure 43. Asia-Pacific NGS-based RNA-seq Revenue Market Share by Regions in 2019
Figure 44. China NGS-based RNA-seq Revenue and Growth Rate (2015-2020)
Figure 45. Japan NGS-based RNA-seq Revenue and Growth Rate (2015-2020)
Figure 46. Korea NGS-based RNA-seq Revenue and Growth Rate (2015-2020)
Figure 47. India NGS-based RNA-seq Revenue and Growth Rate (2015-2020)
Figure 48. Southeast Asia NGS-based RNA-seq Revenue and Growth Rate (2015-2020)
Figure 49. South America NGS-based RNA-seq Revenue Market Share by Countries (2015-2020)
Figure 50. South America NGS-based RNA-seq Revenue Market Share by Countries in 2019
Figure 51. Brazil NGS-based RNA-seq Revenue and Growth Rate (2015-2020)
Figure 52. Argentina NGS-based RNA-seq Revenue and Growth Rate (2015-2020)
Figure 53. Middle East and Africa NGS-based RNA-seq Revenue Market Share by Countries (2015-2020)
Figure 54. Middle East and Africa NGS-based RNA-seq Revenue Market Share by Countries in 2019
Figure 55. Saudi Arabia NGS-based RNA-seq Revenue and Growth Rate (2015-2020)
Figure 56. UAE NGS-based RNA-seq Revenue and Growth Rate (2015-2020)
Figure 57. Egypt NGS-based RNA-seq Revenue and Growth Rate (2015-2020)
Figure 58. South Africa NGS-based RNA-seq Revenue and Growth Rate (2015-2020)
Figure 59. Global NGS-based RNA-seq Revenue Share by Type (2015-2020)
Figure 60. Global NGS-based RNA-seq Revenue Share by Type in 2019
Figure 61. Global NGS-based RNA-seq Market Share Forecast by Type (2021-2025)
Figure 62. Global High-Throughput Sequencing Revenue Growth Rate (2015-2020)
Figure 63. Global Third-Generation Sequencing Technology Revenue Growth Rate (2015-2020)
Figure 64. Global NGS-based RNA-seq Revenue Share by Application (2015-2020)
Figure 65. Global NGS-based RNA-seq Revenue Share by Application in 2019
Figure 66. Global NGS-based RNA-seq Market Share Forecast by Application (2021-2025)
Figure 67. Global Hospitals and Clinics Revenue Growth Rate (2015-2020)
Figure 68. Global Biopharma Companies Revenue Growth Rate (2015-2020)
Figure 69. Global Government Agencies Revenue Growth Rate (2015-2020)
Figure 70. Global Academic and Research Organizations Revenue Growth Rate (2015-2020)
Figure 71. Global Other Revenue Growth Rate (2015-2020)
Figure 72. Global NGS-based RNA-seq Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 73. Global NGS-based RNA-seq Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 74. Global NGS-based RNA-seq Revenue Market Share Forecast by Regions (2021-2025)
Figure 75. North America NGS-based RNA-seq Revenue Market Forecast (2021-2025)
Figure 76. Europe NGS-based RNA-seq Revenue Market Forecast (2021-2025)
Figure 77. Asia-Pacific NGS-based RNA-seq Revenue Market Forecast (2021-2025)
Figure 78. South America NGS-based RNA-seq Revenue Market Forecast (2021-2025)
Figure 79. Middle East and Africa NGS-based RNA-seq Revenue Market Forecast (2021-2025)
Figure 80. Sales Channel: Direct Channel vs Indirect Channel
Please feel free to write an email to us or to use our electronic ticketing system.
